Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Daedalus Special Acquisition Corp.DSAC · Entity 5794 | Director | December 08, 2025 | December 09, 2025 |
| Lemonade, Inc.LMND · Entity 4057 | Director | June 03, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Daedalus Special Acquisition Corp.
Report date December 08, 2025 · Filed December 09, 2025
This filing explicitly reported no securities owned.
Lemonade, Inc.
Report date June 03, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Direct | 24,415 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Grant · Acquired 2,848 · Balance 24,415 F1: Represents an award of restricted stock units, which will vest and become exercisable on the earlier of (i) the day immediately preceding the date of the first annual meeting following the date of the grant and (ii) June 3, 2027. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units, which will vest and become exercisable on the earlier of (i) the day immediately preceding the date of the first annual meeting following the date of the grant and (ii) June 3, 2027. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 5, 2026 21:15 UTC | Lemonade, Inc. LMND · Entity 4057 | GrantCOMMON STOCK | 2,848 | $0.00 | $0.00 |
DisclosureSEC source: 0002000499-26-000002 · wk-form4_1780694119.xml · nonDerivative · entry 1 Schwartz Debra · CIK 0002000499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,415 F1 · shares: Represents an award of restricted stock units, which will vest and become exercisable on the earlier of (i) the day immediately preceding the date of the first annual meeting following the date of the grant and (ii) June 3, 2027. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:32 UTC | Lemonade, Inc. LMND · Entity 4057 | SaleCOMMON STOCK | 4,200 | $83.59 | $351,078.00 |
DisclosureSEC source: 0002000499-25-000003 · wk-form4_1765834374.xml · nonDerivative · entry 1 Schwartz Debra · CIK 0002000499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,567 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions prices ranging from $83.56 to $83.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC | Lemonade, Inc. LMND · Entity 4057 | GrantCOMMON STOCK | 4,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001691421-25-000093 · wk-form4_1749760075.xml · nonDerivative · entry 1 Schwartz Debra · CIK 0002000499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,767 F1 · shares: Represents an award of restricted stock units, which will vest and become exercisable on the earlier of (i) the day immediately preceding the date of the first annual meeting following the date of the grant and (ii) June 4, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 23:01 UTC | Lemonade, Inc. LMND · Entity 4057 | GrantCOMMON STOCK | 9,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001691421-24-000093 · wk-form4_1719442873.xml · nonDerivative · entry 1 Schwartz Debra · CIK 0002000499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,583 F1 · shares: Represents an award of restricted stock units, which will vest and become exercisable on the earlier of (i) the day immediately preceding the date of the first annual meeting following the date of the grant and (ii) June 5, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 20:12 UTC | Lemonade, Inc. LMND · Entity 4057 | GrantCOMMON STOCK | 10,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001691421-23-000132 · wk-form4_1700856733.xml · nonDerivative · entry 1 Schwartz Debra · CIK 0002000499 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,352 F1 · shares: Represents an award of restricted stock units, which will vest in three equal annual installments. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.